Regarding the incidental prostate adenocarcinoma, in other investigations focused on the urinary tract, Cho et al. discovered a notable 10.2% incidence of BRAF codon 600 mutations in prostate adenocarcinomas [46]. This evidence concerns the gene BRAF and prostate adenocarcinoma.